↓ Skip to main content

Interferon beta for secondary progressive multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, January 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

blogs
2 blogs
twitter
3 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
62 Dimensions

Readers on

mendeley
105 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Interferon beta for secondary progressive multiple sclerosis
Published in
Cochrane database of systematic reviews, January 2012
DOI 10.1002/14651858.cd005181.pub3
Pubmed ID
Authors

Loredana La Mantia, Laura Vacchi, Carlo Di Pietrantonj, George Ebers, Marco Rovaris, Sten Fredrikson, Graziella Filippini

Abstract

Therapy with either recombinant beta-1a or beta-1b interferons (IFNs) is worldwide approved for Relapsing Remitting Multiple Sclerosis (RRMS). A major unanswered question is whether this treatment is able to safely reverse or retard the progressive phase of the disease.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 105 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 2%
Turkey 1 <1%
France 1 <1%
Unknown 101 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 21 20%
Student > Master 15 14%
Researcher 14 13%
Student > Postgraduate 11 10%
Student > Bachelor 10 10%
Other 17 16%
Unknown 17 16%
Readers by discipline Count As %
Medicine and Dentistry 45 43%
Psychology 8 8%
Neuroscience 6 6%
Agricultural and Biological Sciences 6 6%
Social Sciences 6 6%
Other 11 10%
Unknown 23 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2019.
All research outputs
#1,163,664
of 15,621,847 outputs
Outputs from Cochrane database of systematic reviews
#3,172
of 11,224 outputs
Outputs of similar age
#12,982
of 219,049 outputs
Outputs of similar age from Cochrane database of systematic reviews
#138
of 511 outputs
Altmetric has tracked 15,621,847 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,224 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.3. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 219,049 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 511 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.